Holen Sie sich die Stockscreener-App
54.46
3.77%
1.98
Handel nachbörslich:
54.50
0.04
+0.07%
Schlusskurs vom Vortag:
$52.48
Offen:
$53.6
24-Stunden-Volumen:
2.14M
Relative Volume:
0.85
Marktkapitalisierung:
$8.27B
Einnahmen:
$3.44B
Nettoeinkommen (Verlust:
$75.20M
KGV:
103.95
EPS:
0.5239
Netto-Cashflow:
$49.30M
1W Leistung:
+13.20%
1M Leistung:
+20.06%
6M Leistung:
+29.30%
1J Leistung:
-10.65%
1-Tages-Spanne:
$52.20
$54.57
1-Wochen-Bereich:
$47.74
$54.57
52-Wochen-Spanne:
$28.53
$64.64
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
54.46 | 7.97B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Why Is Bruker Stock Gaining Friday?Bruker (NASDAQ:BRKR) - Benzinga
Bruker (BRKR) Secures $500M in Multi-Year Superconductor Agreeme - GuruFocus
Bruker secures $500 million in superconductor supply deals for MRI systems - Investing.com
Bruker acquires additional 60% stake in Tofwerk, terms undisclosed - Yahoo Finance
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI (2026-01-09) - Seeking Alpha
Will Bruker Corporation stock outperform growth indexesMarket Trend Summary & Weekly Return Optimization Alerts - ulpravda.ru
Will Bruker Corporation (BKD) stock outperform foreign stocksJuly 2025 Institutional & Pattern Based Trade Signal System - ulpravda.ru
Is Bruker Corporation stock a defensive play in 2025Market Performance Summary & Risk Controlled Stock Pick Alerts - ulpravda.ru
Bruker acquires remaining 60% stake in TOFWERK for full ownership By Investing.com - Investing.com Canada
Bruker deal expands TOF tech for cleaner air and semiconductor cleanrooms - Stock Titan
How to listen in as Bruker joins J.P. Morgan's big health event - Stock Titan
Is Bruker (BRKR) Pricing Reflecting Its Life Sciences Role And Mixed Valuation Signals? - Yahoo Finance
Bruker Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Bruker (BRKR) Is Up 7.9% After Winning €35 Million ELI-NP Order In Romania - simplywall.st
Winners And Losers Of Q3: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $53 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Finviz
AbCellera settles patent litigation with Bruker over microfluidic device tech - MSN
Bruker (BRKR) Receives Analyst Rating and Price Target Upgrade f - GuruFocus
Benchtop X-Ray Diffraction Platform | Bruker AXS GmbH | Jul 2023 - Photonics Spectra
Insider Stock Buying Reaches US$1.14m On Bruker - 富途牛牛
Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern - MSN
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) Competitors - Meyka
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide - AOL.com
Should You Continue to Hold BRKR Stock in Your Portfolio? - Finviz
Bruker (BRKR) Is Up 6.8% After Settling AbCellera Dispute And Securing Major ELI-NP Contracts - Yahoo Finance
Does Bruker’s 2025 Share Price Slide Present a Hidden Opportunity? - Yahoo Finance
3D Measuring Device | Bruker Alicona | May 2024 - Photonics Spectra
Bruker (BRKR) Valuation Check After €35m ELI-NP Contract Win Drives Fresh Growth Hopes - Yahoo Finance
Bruker Corporation $BRKR Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Bruker (MIL:1BRKR) EV-to-OCF : 73.37 (As of Dec. 20, 2025) - GuruFocus
Will AbCellera’s (ABCL) Bruker Patent Settlement and Royalties Shift Its Long-Term Revenue Narrative? - simplywall.st
Why Bruker Corporation stock appeals to dividend seekersMarket Trend Review & Weekly Watchlist for Consistent Profits - DonanımHaber
Will Bruker’s (BRKR) AbCellera Settlement and Beacon Royalties Deal Change Its Investment Narrative? - simplywall.st
Will Bruker Corporation stock continue upward momentumMarket Growth Summary & Real-Time Stock Movement Alerts - Улправда
Why Bruker Corporation stock is rated strong buy2025 Buyback Activity & Long-Term Safe Investment Plans - ulpravda.ru
Can Bruker Corporation stock maintain growth trajectoryWeekly Investment Report & Long Hold Capital Preservation Tips - ulpravda.ru
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
Bruker (BRKR) Agrees to $36M Settlement with AbCellera (ABCL) - GuruFocus
AbCellera settles patent dispute with Bruker for $36 million upfront - Investing.com
AbCellera and Bruker Reach Global Settlement of Patent Litigation - Yahoo Finance
Volume Summary: Will Bruker Corporation stock continue upward momentumProfit Target & High Return Stock Watch Alerts - ulpravda.ru
How Recent Analyst Shifts Are Reshaping The Bruker Investment Story - Yahoo Finance
YieldBoost Bruker From 0.4% To 11.2% Using Options - Nasdaq
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $55 to $60 - 富途牛牛
Bruker Corporation $BRKR Shares Sold by Squarepoint Ops LLC - MarketBeat
Reassessing Bruker’s 2025 Valuation After Share Price Rebound And Life Sciences Expansion - simplywall.st
Bruker Is Maintained at Overweight by Barclays - 富途牛牛
Wells Fargo Raises Bruker (BRKR) Price Target to $55 | BRKR Stoc - GuruFocus
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Bank of America Raises Bruker (NASDAQ:BRKR) Price Target to $60.00 - MarketBeat
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):